Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3
Event:
ESC Congress 2025
Topic:
Pharmacotherapy
Session:
Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention